ASHLEY CARNEGIE: Open Payments
NPI 1427719376 · ELDERSBURG, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,525 in 63 payments from 23 companies in 2025. Trend: 2023 $1,415 · 2024 $872 · 2025 $1,525
Food & beverage: $1,525
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 12 | $287 |
| AstraZeneca Pharmaceuticals LP | 7 | $229 |
| Viatris Specialty LLC | 6 | $200 |
| Corcept Therapeutics | 4 | $97 |
| Regeneron Healthcare Solutions, Inc. | 3 | $85 |
| Grifols USA, LLC | 3 | $76 |
| Avadel CNS Pharmaceuticals, LLC | 4 | $72 |
| Axsome Therapeutics, Inc. | 3 | $72 |
| Bausch Health US, LLC | 2 | $47 |
| Novo Nordisk Inc | 2 | $47 |
Products named: NUCALA, YUPELRI, AIRSUPRA, DUPIXENT, Korlym, LUMRYZ, Sunosi, WELLBUTRIN.
Industry payments across MD — which companies pay providers there.
